Astra Zeneca is expected to apply for conditional marketing authorization for its COVID-19 vaccine next week, the European Medicine Agency (EMA) said Friday.
“After having received more data from the company, EMA is expecting Astra Zeneca to submit a conditional marketing application for its #COVID19vaccine next week,” said the EMA on Twitter.
“Possible conclusion – end of Jan, depending on data and evaluation progress,” it added.
The European Union authorized the use of COVID-19 vaccines from BioNTech/Pfizer on Dec. 21, and Moderna on Wednesday.
Copyright 2021 Anadolu Agency. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.